Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Anixa Biosciences IncITUS · Entity 6698 | Director | April 09, 2018 | April 11, 2018 |
| Vinco Ventures, Inc.XSPL · Entity 113116 | Director | April 04, 2018 | April 12, 2018 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Anixa Biosciences Inc
Report date April 09, 2018 · Filed April 11, 2018
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 25,000 |
Reported balance
After 2018-04-09 transaction · row 1
1 source rowRow 1 · 2018-04-09 · Sale · Disposed 25,000 · Balance 25,000 |
Vinco Ventures, Inc.
Report date April 04, 2018 · Filed April 12, 2018
This filing explicitly reported no securities owned.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| April 09, 2018 Filed Apr 11, 2018 17:39 UTC | Anixa Biosciences Inc ITUS · Entity 6698 | SaleCommon Stock | 25,000 | $4.64 | $116,000.00 |
DisclosureSEC source: 0001513162-18-000096 · primary_doc.xml · nonDerivative · entry 1 WILLIAMS RICHARD H · CIK 0001105378 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,000 Read SEC document |
| September 22, 2017 Filed Oct 2, 2017 17:35 UTC | Anixa Biosciences Inc ITUS · Entity 6698 | GrantEmployee Stock Options (right to Buy) · Derivative | 50,000 | $0.00 Strike: $2.27 | $0.00 |
DisclosureSEC source: 0001513162-17-000276 · primary_doc.xml · derivative · entry 3 WILLIAMS RICHARD H · CIK 0001105378 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,000 Underlying: Common Stock · 50,000 shares Expires 2027-09-22 F2 · security: Right-To-Buy, pursuant to the Plan. F3 · derivative.exercise_date: The options vest and become exercisable in four (4) equal installments on each of December 31, 2017, March 31, 2018, June 30, 2018 and September 30, 2018. Read SEC document |
| September 22, 2017 Filed Oct 2, 2017 17:35 UTC | Anixa Biosciences Inc ITUS · Entity 6698 | GrantEmployee Stock Options (right to Buy) · Derivative | 50,000 | $0.00 Strike: $2.27 | $0.00 |
DisclosureSEC source: 0001513162-17-000276 · primary_doc.xml · derivative · entry 2 WILLIAMS RICHARD H · CIK 0001105378 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,000 Underlying: Common Stock · 50,000 shares Expires 2027-09-22 F2 · security: Right-To-Buy, pursuant to the Plan. F3 · derivative.exercise_date: The options vest and become exercisable in four (4) equal installments on each of December 31, 2017, March 31, 2018, June 30, 2018 and September 30, 2018. Read SEC document |
| September 22, 2017 Filed Oct 2, 2017 17:35 UTC | Anixa Biosciences Inc ITUS · Entity 6698 | GrantCommon Stock | 50,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001513162-17-000276 · primary_doc.xml · nonDerivative · entry 1 WILLIAMS RICHARD H · CIK 0001105378 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Williams Resource Group, Inc. Disclosed balance after: 100,000 F1 · security: Stock Award granted under the ITUS Corporation 2010 Share Incentive Plan (the "Plan"). F1 · price: Stock Award granted under the ITUS Corporation 2010 Share Incentive Plan (the "Plan"). Read SEC document |
| September 22, 2017 Filed Apr 11, 2018 17:31 UTC Amendment | Anixa Biosciences Inc ITUS · Entity 6698 | GrantEmployee Stock Options (right to Buy) · Derivative | 50,000 | $0.00 Strike: $2.27 | $0.00 |
DisclosureSEC source: 0001513162-18-000095 · primary_doc.xml · derivative · entry 3 WILLIAMS RICHARD H · CIK 0001105378 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,000 Underlying: Common Stock · 50,000 shares Expires 2017-09-22 F2 · security: Right-To-Buy, pursuant to the Plan. F3 · derivative.exercise_date: The options vest and become exercisable in four (4) equal installments on each of December 31, 2017, March 31, 2018, June 30, 2018 and September 30, 2018. Read SEC document |
| September 22, 2017 Filed Apr 11, 2018 17:31 UTC Amendment | Anixa Biosciences Inc ITUS · Entity 6698 | GrantEmployee Stock Options (right to Buy) · Derivative | 50,000 | $0.00 Strike: $2.27 | $0.00 |
DisclosureSEC source: 0001513162-18-000095 · primary_doc.xml · derivative · entry 2 WILLIAMS RICHARD H · CIK 0001105378 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,000 Underlying: Common Stock · 50,000 shares Expires 2017-09-22 F2 · security: Right-To-Buy, pursuant to the Plan. F3 · derivative.exercise_date: The options vest and become exercisable in four (4) equal installments on each of December 31, 2017, March 31, 2018, June 30, 2018 and September 30, 2018. Read SEC document |
| September 22, 2017 Filed Apr 11, 2018 17:31 UTC Amendment | Anixa Biosciences Inc ITUS · Entity 6698 | GrantCommon Stock | 50,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001513162-18-000095 · primary_doc.xml · nonDerivative · entry 1 WILLIAMS RICHARD H · CIK 0001105378 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Williams Resource Group, Inc. Disclosed balance after: 50,000 F1 · security: Stock Award granted under the ITUS Corporation 2010 Share Incentive Plan (the "Plan"). F1 · price: Stock Award granted under the ITUS Corporation 2010 Share Incentive Plan (the "Plan"). Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.